A decrease in CSF levels of NP1 has been found in AD (18) while plasma NP1 levels were abnormally high in older adults with mild cognitive impairment and even higher in the subset of individuals who progressed to early-stage AD (19). The gene discussed is NPTX1; the disease is Cognitive impairment.